Skip to content

Role of Gandamalakandana Rasa in the Management of Dhatwagnimandhya w.s.r. to Hypothyroidism

Clinical evaluation of Gandamalakandana Rasa in the Management of Dhatwagnimandhya w.s.r. to Hypothyroidism: A randomized control trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027937
Enrollment
60
Registered
2020-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

Intervention1: Gandamalakandan Ras: Dose -500 mg Frequency -thrice in a day Route of administration- oral Duration of therapy -60 days Control Intervention1: Tab. Thyroxine: Dose -1.7 µg/kg Frequenc

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Between the age of 18-60 years. 2.Patients who are newly diagnosed OR mild cases of Hypothyroidism with increased TSH levels (TSH level between 5.5-20 µIU/ml) 3.Patients who are ready to switch over to Ayurvedic medicine and have signed the consent form. 4.Patients who are already diagnosed as hypothyroidism and under Levo-thyroxine medication but still presenting with the increased TSH levels. 5. 4 out of 6 major symptoms and minor symptoms may or may not be present.

Exclusion criteria

Exclusion criteria: 1.Patients below 18 yrs and above 60 yrs of age. TSH level above 20µIU/ml. 2.Patients suffering from congenital hypothyroidism and secondary hypothyroidism. Pregnant women, hyperthyroidism, neoplasia, toxic goitre are excluded. 3.Patients who have under gone any type of thyroid surgery. 4.Patients whose symptoms are worsely aggravated after leaving the modern drug Levo-thyroxine (for washout period). 5.Patients suffering from systemic diseases like cardiac problems, diabetes, carcinomas etc. 6.Drug induced hypothyroidism.

Design outcomes

Primary

MeasureTime frame
1. Change in body weight and BMI before and after the treatment. 2. Change in Thyroid profile before and after the treatment. Timepoint: 60days

Secondary

MeasureTime frame
Change in Subjective ParametersTimepoint: 60days

Countries

India

Contacts

Public ContactDr ArunKumarGarg

National Institute of Ayurveda

drajaysahu@gmail.com9950708106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026